Christopher M Dwyer

4PUBLICATIONS
22CO-AUTHORS
Gene and molecular therapyMedical infection agents (incl. prions)Respiratory diseasesCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 22, 2025
COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection.

Avani Yeola, Samuel Houston, Anupriya Aggarwal

|Dec 27, 2023
HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS.

Michele D Binder, Eze C Nwoke, Ellen Morwitch

|Sep 14, 2023
Rates of John Cunningham virus seroconversion greatly reduced in natalizumab-treated patients during COVID-19-related lockdowns.

Chris Dwyer, Sifat Sharmin, Tomas Kalincik

|May 05, 2021
High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients.

Christopher M Dwyer, Vilija G Jokubaitis, Jim Stankovich

Pageof 1

Frequent Collaborators

2 joint publications

Tomas Kalincik

2 joint publications

Jeannette Lechner-Scott

2 joint publications

Anneke Van Der Walt

1 joint publications

Michele D Binder